NCT07476560 Evaluating the Efficacy of Suture Mesh vs. Planar Mesh in Ventral Hernia Treatment
| NCT ID | NCT07476560 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Regionshospital Nordjylland |
| Condition | Abdominal Wall Hernia |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2026-01-05 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2026-01-05 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate whether mesh-suture affects wound complication rates, patient-reported quality of life, and operation time in adult patients undergoing surgery for small ventral hernias. The main questions it aims to answer are: Does mesh-suture reduce wound complication rates compared to planar mesh? Does mesh-suture improve patient-reported quality of life(QoL) and affect operation time compared to planar mesh? Comparison group: Researchers will compare standard treatment with planar mesh to the interventional treatment with mesh-suture to see whether mesh-suture leads to fewer complications, better quality of life, and shorter operation time. Participants will: Be randomized to receive either planar mesh or mesh-suture during hernia repair surgery. Undergo standardized preoperative assessment, including baseline data and QoL scoring. Attend a postoperative visit on day 7-13 for wound inspection and ultrasound. Complete QoL assessments at 90 days (telephone follow-up). Have operation time recorded and medical records reviewed for readmissions within 90 days.
Eligibility Criteria
Inclusion Criteria: * Ventral hernia (maximum size 3 × 3 cm) measured with Ultrasound or CT. * Participants must be eligible for surgical repair using either mesh-suture or planar mesh Exclusion Criteria: * Age \< 18 years. * Acute (emergent) operation. * Pregnancy. * Women with plans for future pregnancies. * Withdrawal of informed consent during admission.
Contact & Investigator
Nils Brandenburger
STUDY CHAIR
Regionhospital Nordjylland
Frequently Asked Questions
Who can join the NCT07476560 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Abdominal Wall Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07476560 currently recruiting?
Yes, NCT07476560 is actively recruiting participants. Contact the research team at vitgam@rn.dk for enrollment information.
Where is the NCT07476560 trial being conducted?
This trial is being conducted at Hjørring, Denmark.
Who is sponsoring the NCT07476560 clinical trial?
NCT07476560 is sponsored by Regionshospital Nordjylland. The principal investigator is Nils Brandenburger at Regionhospital Nordjylland. The trial plans to enroll 280 participants.